Pancreatic Neoplasms D010190

Related MeSH Hierarchy (5)

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Endocrine Gland Neoplasms » Pancreatic Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Pancreatic Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Pancreatic Diseases » Pancreatic Neoplasms

Diseases [C] » Endocrine System Diseases [C19] » Endocrine Gland Neoplasms » Pancreatic Neoplasms

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Pancreatic Neoplasms

Description

Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).   MeSH

Subtype Terms (4)

Adenoma, Islet Cell
20 drugs (18 approved, 2 experimental)

Carcinoma, Islet Cell
28 drugs (22 approved, 6 experimental)

Carcinoma, Pancreatic Ductal
23 drugs (13 approved, 10 experimental)

Pancreatic Intraductal Neoplasms
5 approved drugs


Phase 2 Indicated Drugs (410)

13c-pyruvate

177lu-dota0-tyr3-octreotate

177lu-dotatoc

2-fluoropropionyl-labeled pegylated dimeric rgd peptide

2-o, 3-o desulfated heparin

3bp-227

68ganota-anti-her2 vhh1

68ga-ops202

7-hydroxystaurosporine

9-ing-41

abbv-927

abemaciclib (verzenio)

acalabrutinib (calquence)

activated cik and cd3-muc1 bispecific antibody

ad5.f35-hgcc-padre

ad5-ycd/muttksr39rep-adp

adc-1013

adenoviral vector expressing hsv-tk

afatinib (gilotrif)

agen1884

ags-1c4d4

aguix

aldesleukin (proleukin)

aldoxorubicin

alectinib (alecensa)

allogeneic mononuclear cells

allogeneic tumor cell vaccine

allogenic gm-csf plasmid-transfected pancreatic tumor cell vaccine

alt-803

alvac-cea vaccine

alvocidib

amatuximab

anakinra (kineret)

anamorelin

anetumab ravtansine

anlotinib

anti-kras g12v mtcr

antineoplaston a10

apatinib

apatorsen

apg-1387

apricoxib

apx005m

arsenic trioxide (trisenox)

atezolizumab (tecentriq)

autologous CD276 car-T cells

autologous dendritic cells loaded with autologous tumor lysate

autologous gp96 vaccination

autologous lymphocytes

autologous t cells

autologous tumor infiltrating lymphocytes

auy922

avb-s6-500

avelumab (bavencio)

avn-944

axitinib (inlyta)

azacitidine (vidaza)

azd-4547

azd5069

azd-5672

azd6738

azd9150

bavituximab

bbr 3464

beta-lapachone

bey1107

bi-2536

binimetinib (mektovi)

bintrafusp alfa

bkt-140

bms-813160

bortezomib (velcade)

bosutinib (bosulif)

br55

brivanib alaninate

bromovinyldeoxyuridine

bryostatin

budigalimab

bupropion (wellbutrin)

cabiralizumab

calcitriol (rocaltrol)

calcium

can04

cannabidiol (Epidiolex)

cap1-6d

carboplatin (paraplatin)

carcinoembryonic antigen peptide 1

carmustine (bicnu)

cbp 501

cbp8

cc-223

ccx872-b

cdx-1140

cdx-301

cediranib

cemiplimab (libtayo)

cend-1

ceritinib (zykadia)

cg 2505

cg 8020

chlorambucil (Leukeran)

ci-1040

cimetidine (tagamet)

cinobufacini

cixutumumab

cmp-001

cobimetinib (cotellic)

conatumumab

copper gluconate

cpi-613

crizotinib (xalkori)

crs-207

cv301

cvac

cyanocobalamin (berocca)

cyclophosphamide (cytoxan)

dabrafenib (tafinlar)

dacarbazine (dtic-dome)

dactolisib

dasatinib (sprycel)

defactinib

demcizumab

denileukin diftitox (ontak)

detoxpc

diclofenac (voltaren)

digoxin (lanoxin)

diphenhydramine (benadryl)

dipyridamole (persantine)

disulfiram (antabuse)

dolastatin

donafenib

dostarlimab

dovitinib

doxorubicin (Doxil)

doxycycline (vibramycin)

durvalumab (imfinzi)

efavirenz (sustiva)

egfr bats

emactuzumab

encorafenib (braftovi)

endostatin (endostar)

enmd 2076

ensituximab

entinostat

entrectinib (Rozlytrek)

enzastaurin

epacadostat

epoetin (Epogen)

eribulin (halaven)

ery001

etalocib

etbx-011

etbx-021

etbx-051

etbx-061

etodolac (lodine)

etoposide (vepesid)

famitinib

ferric carboxymaltose (Injectafer)

fludarabine (fludara)

fludeoxyglucose f-18

fluorocyclopentenylcytosine

fluoromisonidazole

fluorothymidine

galeterone

gallium-68-dotatate (netspot)

galunisertib

ganetespib

gb1275

gc4711

gefitinib (iressa)

gen1042

genistein

gi-4000

gi-6207

gi-6301

gimatecan

glutathione

gm-neo and panc 6.03 pcdna-1

gp-2250

gpc3 car-t cell

gsk2256098

gsk-2636771

gsk3145095

gvax pancreatic cancer vaccine

hyaluronidase (human recombinant) (hylenex)

hydroxychloroquine (plaquenil)

hydroxyurea (hydrea)

ifosfamide (ifex)

imatinib (gleevec)

imexon

imm-101

in111-octreoscan

inactivated influenza vaccine

incagn01949

incmga00012

incomplete freund's adjuvant

indoximod

infigratinib

infliximab (remicade)

inodiftagene vixteplasmid

interferon alpha-2a (roferon-a)

interferon alpha-2b (Intron-A)

interferon gamma-1b (actimmune)

iobenguane sulfate i-131

ipilimumab (yervoy)

isis 2503

ixabepilone (ixempra)

kanglaite

klh-pulsed autologous dendritic cell vaccine

l-alanine

landogrozumab

lapatinib (tykerb)

larotrectinib (vitrakvi)

lenalidomide (revlimid)

lenvatinib (lenvima)

lidocaine (xylocaine)

linsitinib

load703

lomustine

losartan (cozaar)

lutetium (177lu) oxodotreotide

ly-3023414

ly3214996

m9241

magnesium oxide

mcla-128

mcs110

mdna11

melphalan (alkeran)

mesothelin car t cells

metenkefalin

metformin (glucophage)

methoxsalen

minnelide

minocycline (minocin)

mitoxantrone (novantrone)

mk-0646

mk-1775

mk-6482

mln0264

mm-141

Motixafortide

msk-2206

muc1 car-t cells

mvt-5873

n803

nanoplatin

necuparanib

nedisertib

nelfinavir (viracept)

ngm707

nir178

niraparib (zejula)

nivolumab (opdivo)

nk-92

nlm-001

norzyme

obi-3424

octreotate

olaptesed pegol

olaratumab (lartruvo)

oleclumab

omt-111

onabotulinumtoxinA (Botox)

oncoxin-viusid

onvansertib

opioid growth factor

oregovomab

ose2101

osimertinib (tagrisso)

palbociclib (ibrance)

palonosetron (aloxi)

panc 10.05 pcdna-1

pancrelipase (creon)

panitumumab (vectibix)

panobinostat (farydak)

paricalcitol (zemplar)

pazopanib (votrient)

pbi-05204

pci-27483

pd-l1/ctla4 bsab

pd-l1 t-hank

pegph20

pen-866

penpulimab

pepinemab

perflubutane

perifosine

perillyl alcohol

pertuzumab (perjeta)

pf-04136309

pf3084014

phenylacetic acid (ucephan)

phenylacetylgluatmine

phenytoin (mesantoin)

pidilizumab

pimasertib

pioglitazone (actos)

plerixafor (mozobil)

porfimer (photofrin)

propranolol (inderal)

px-12

qyhj

Raltitrexed

ramucirumab (cyramza)

ras peptide cancer vaccine

rav12

recombinant adenoviral human p53 gene

recombinant human il12/15-pdl1b oncolytic hsv-1 injection (vero cell))

regorafenib (stivarga)

reolysin

reparixin

ribociclib (kisqali)

rituximab (rituxan)

rivaroxaban (xarelto)

ro4929097

ro6874281

romidepsin (istodax)

rovalpituzumab tesirine

rucaparib (rubraca)

rx-0201

salmonella-il2

sapanisertib

sar408701

saracatinib

saridegib

satoreotide trizoxetan

sco-101

selicrelumab

selinexor (Xpovio)

selumetinib

seribantumab

sgt-53

sig12d loder

siltuximab (sylvant)

simtuzumab

simvastatin (zocor)

sirolimus (rapamune)

slc-0111

sonidegib (odomzo)

spartalizumab

sulfasalazine (azulfidine)

tacedinaline

tadalafil (cialis)

tak-931

talabostat

talazoparib (talzenna)

tanespimycin

tarextumab

tas-102

taselisib

taxoprexin

tazemetostat

tc 99m ec20

tegavivint

telotristat ethyl (xermelo)

temozolomide (temodar)

temsirolimus (torisel)

tetanus toxoid

tetrahydrocannabinol

tew-7197

thalidomide (Thalomid)

therasphere

thergap-02

tigatuzumab

tipiracil (lonsurf)

tislelizumab

tisotumab vedotin

tivantinib

tivozanib (Fotivda)

tnp-470

tocilizumab (actemra)

toripalimab

tpi-287

trabectedin (yondelis)

trametinib (mekinist)

trastuzumab (herceptin)

trastuzumab emtansine (kadcyla)

tremelimumab

tretinoin (Retin-A)

triapine

trimetrexate (neutrexin)

trx-818

tumour infiltrating lymphocytes

ubidecarenone

upamostat

v3-p

vaccinia-cea vaccine

valaciclovir (Valtrex)

valproic acid (depakene)

vancomycin (Vancocin)

vandetanib (caprelsa)

vatalanib

veliparib

vemurafenib (zelboraf)

verteporfin (visudyne)

vismodegib (erivedge)

vls-101

volociximab

vorinostat (zolinza)

wild-type reovirus

y90 glass microspheres

yh003

young tumor infiltrating lymphocytes

z-360

zb131

zen-3694

zolbetuximab

zoledronic acid (zometa)

Phase 1 Indicated Drugs (289)


Organization Involved with Phase 3 Indications (201)

Organization Involved with Phase 2 Indications (410)

Aarhus University

Abbott

Ability Pharmaceuticals SL

Academic and Community Cancer Research United

Acerta Pharma

ACT Genomics

Actuate Therapeutics Inc.

Adastra Pharmaceuticals

Aduro BioTech

Advanced Accelerator Applications

Agensys, Inc.

Allergan

Altor Bioscience

American Association for Cancer Research

AmpliMed Corporation

Anchiano Therapeutics

Apices Soluciones S.L.

ARCAGY-GINECO

Ariake Hospital

Aronex Pharmaceuticals

ArQule

Array BioPharma

Ascentage Pharma Group Inc.

Asociación de Oncología Médica del Hospital de Cruces

Astellas

Augusta University

Aventis

Avid Bioservices

Battle Creek Health System

Baxalta

Bayer

Baylor University

B. Braun

Belarusian State Medical University

Ben Gurion University

Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

BerGenBio ASA

Berg, LLC

BeyondBio Inc.

Bicycle Therapeutics

Big Ten Cancer Research Consortium

BioLineRx, Ltd.

Boehringer Ingelheim

Bristol-Myers Squibb

British Columbia Cancer Agency

Brown University

Bruckner Oncology

Burzynski Research Institute

Cancer Treatment Centers of America

Cancer Trials Ireland

Cantex Pharmaceuticals

Cardiff University

CARsgen Therapeutics, Ltd.

Cascadian Therapeutics Inc.

Case Western Reserve University

CASI Pharmaceuticals, Inc.

Catalysis SL

Celldex Therapeutics

Cell Genesys

Center for Molecular Medicine

Centocor

Central European Society for Anticancer Drug Research (CESAR)

Central India Cancer Research Institute, Nagpur

Chang Gung University

Changhai Hospital

Changzhou No.2 People's Hospital

Chiltern International

China Medical University

Chinese Academy of Medical Sciences

Chongqing Precision Biotech Co., Ltd

Chung-Ang University

City of Hope National Medical Center

ClinAssess GmbH

Clinica Universidad de Navarra

Clovis Oncology

CNAO National Center of Oncological Hadrontherapy

Cold Spring Harbor Laboratory

COMPLEJO HOSPITALARIO REGIONAL VIRGEN DE LAS NIEVES

Cortice Biosciences, Inc.

Covance

CrystalGenomics, Inc.

Curie Manavata Cancer Center, Nashik, India

Dartmouth University

Deenanath Mangeshkar Hospital & Research Centre

Destroy Pancreatic Cancer

Developmental Therapeutics Consortium

Digestive Care, Inc.

Diverse Biotech

Dong-A University

Duke University

East Carolina University

Eastchester Center for Cancer Care

Endocyte

Epeius Biotechnologies

ERYtech Pharma

Esperas Pharma Inc.

Everfront Biotech Co., Ltd.

FeRx

Foundation IRCCS San Matteo Hospital

Free University of Amsterdam

Fujian Medical University

Fukushima Medical University

Galera Therapeutics

Garden State Cancer Center

Genentech

General Oncology, Inc.

Genmab

Genzyme

Gilead Sciences

GISCAD Foundation

GlaxoSmithKline

Global Hospital, Hyderabad

GlobeImmune

Golden Biotechnology Corp.

Goshen Health System

Government of Australia

Government of Taiwan

Grand Rapids Clinical Oncology Program

Green Cross Corporation

Griffith University

Grupo Espanol de Tumores Neuroendocrinos (GETNE)

Grupo Hospital de Madrid

Guangzhou University

GWT-TUD GmbH

Gyeongsang University

Hacettepe University

Hackley Hospital

Hallym University

Halozyme Therapeutics

Hangzhou Cancer Hospital

Harbin Medical University

Harris County Hospital District

Hebrew University

Hefei University

Helix BioPharma Corporation

Hellenic Cooperative Oncology Group

Hellenic Oncology Research Group

Henan Medical University

Henry Ford Health System

Hokkaido University

HonorHealth Research Institute

Hoosier Cancer Research Network

Hospicare Inc.

Hospital de Toledo, Spain

Hospital HM Universitario Sanchinarro

Hospital Universitario de Fuenlabrada

Hospital Universitario Madrid Sanchinarro

Ignyta, Inc.

Imaging Endpoints

Imclone

Immodulon Therapeutics Ltd

Immunex

Immunitor LLC

ImmunityBio, Inc.

Immutep S.A.

Infinity Pharmaceuticals, Inc.

Institut Bergonié

Institut Català d'Oncologia

Institut de Cancérologie de Lorraine

Institute for Developmental Cancer Therapeutics

Institut Gustave Roussy

Instituto do Cancer do Estado de São Paulo

Insys Therapeutics Inc

Interdisziplinare Arbeitsgruppe Gastrointestinaler Tumore der Deutschen Krebsgesellschaft

Ionis Pharmaceuticals, Inc.

Ipsen

IQVIA

Isala Clinics, Zwolle, The Netherlands

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto Nazionale per lo Studio e la Cura dei Tumori

James Graham Brown Cancer Center

Japan Adjuvant Study Group of Pancreatic Cancer

Japan Agency for Medical Research and Development

Japan Clinical Cancer Research Organization

Jazz Pharmaceuticals

Jeil Pharmaceutical Co., Ltd.

Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd

Jinan University

Juntendo University

Kaohsiung Medical University

Katholieke Universiteit Leuven

King Abdul-Aziz University

Kliniken Nordoberpfalz AG Klinikum Weiden Medizinische Kliniken I

Konkuk University

Lee's Pharmaceutical

Leiden University

Leo W. Jenkins Cancer Center

Lexicon Pharmaceuticals

LGC Limited

Lifeline Mutispecilaity Hospital, Chennai, India

Lokon Pharma AB

Loma Linda University

Loyola University

Lustgarten Foundation

Maastricht University

Mackay Medical College

MacroGenics

Mario Negri Institute

Mary Crowley Cancer Center

McGill University

Mecosta County General Hospital

Medical Research Council

Medical University of South Carolina

MediGene

Meenakshi Ammal Dental College and Hospital

Merck

Mereo BioPharma

Merus Labs

Methodist Cancer Center, Houston, Texas

Meyer Pharmaceuticals

Millennium Pharmaceuticals

Minneamrita Therapeutics LLC

MLM Medical Labs GmbH

Momenta Pharmaceuticals

Moorgreen Hospital, Southampton

Morphotek

Munson Medical Center

Nagoya University

NantWorks

National Cancer Center, Korea

National Cancer Institute, France

National Comprehensive Cancer Network

National Guard Health Affairs

National Institutes of Health (NIH)

National Taiwan University

National University of Malaysia

Netherlands Cancer Institute

New Mexico Cancer Care Alliance

New York Medical College

New York University

NKMAX Co., Ltd.

Northampton General Hospital

North Central Cancer Treatment Group

Northeast Ohio Medical University

Novacea

Novartis

Novatrials

NovoCure Ltd.

Noxxon AG

Oddzial Chemioterapii Krakow

Oddzial Kliniczny Kliniki Onkologii

Oddzial Onkologii Klinicznej im L Rydygiera

OHSU Knight Cancer Institute

Oklahoma Oncology

OncoGenex Technologies

Ono Pharmaceuticals

Ontario Institute for Cancer Research

Oregon Health and Science University

Osaka Medical Center for Cancer and Cardiovascular Diseases

Osakidetza

Pancreatic Cancer Research Team

Parexel

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Pharmacyclics

PharmaEngine

Pharma Valley Center

Pharmbio Korea

Philipps University of Marburg

PH Research, S.L.

PhytoCeutica

Piedmont Cancer Institute

Piramal

Point Therapeutics

Precision Biologics, Inc

Princeton University

Professor Cunningham's Clinical Research Fund

Prologue Research International

PureTech

Queen Elizabeth Hospital NHS Foundation Trust

Queen's University, Belfast

Rafael Pharmaceuticals Inc.

Reata Pharmaceuticals, Inc.

Regionalny Szpital Specjalistyczny Latawiec

Rexahn Pharmaceuticals, Inc.

Rgene Corporation

Riveria Country Club Organization

Royal Marsden Hospital NHS Trust

R-Pharm

Rush University

Sabinsa Corporation

Salk Institute for Biological Studies

Sanofi-Aventis

Sanofi-Synthelabo

Schering-Plough

Scottsdale Healthcare

SCRI Development Innovations

Seattle Cancer Treatment and Wellness Center

Seattle Genetics

Shanghai Asclepius Meditec Inc.

Shenzhen Hank Bioengineering Institute

Silenseed Ltd

SLS Oncology, LLC

Soonchunhyang University

South Plains Oncology Consortium

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Sri Ramachandra Medical College, Chennai

Stand Up To Cancer

State University of New York, Buffalo

St. Vincent Medical Center - Los Angeles

Sun Yat-Sen University

Surgimab

Susan L Bader Foundation of Hope

SWAN Isotopen AG, Bern

Swiss Cancer League

Swiss National Science Foundation

Syndax Pharmaceuticals

SynerGene Therapeutics, Inc.

Taipei Medical University

Taipei Veteran General hospital

Taiwan Cooperative Oncology Group

Targovax ASA

Technostat

Tennessee Oncology, PLLC

Tesaro

TGen Drug Development

Theradex

The Republican Center for Research and Practice in Otolaryngology, Belarus

The Republican Research and Practical Center for Epidemiology and Microbiology

The Spectrum Health Group

Tiltan Pharma

Tokyo Medical University

Tokyo Metropolitan Komagome Hospital

Translational Drug Development

Translational Oncology Research International

Trans Tasman Radiation Oncology Group

Triligent International

Trinity College Dublin

Tsinghua University

Tyme, Inc

United BioSource Corporation

Universidad Autonoma de Barcelona

Universidad Carlos III Madrid

Universidad Complutense de Madrid

Universitario de Santiago, Spain

University of Amsterdam

University of Arizona

University of Athens

University of Bern

University of Caen-Normandie

University of California, Los Angeles

University of California, San Diego

University of California, San Francisco

University of Cincinnati

University of Colorado

University of Copenhagen

University of Crete

University of Edinburgh

University of Florida

University of Genoa

University of Glasgow

University of Grenoble

University of Hawaii

University of Hull

University of Ioannina

University of Kansas

University of Lausanne

University of Leicester

University of Louisville

University of Manchester

University of Maryland

University of Massachusetts

University of Medicine and Dentistry of New Jersey

University of Miami

University of Michigan

University of Minnesota

University of Montpellier

University of Naples Frederico II

University of Nebraska

University of New Mexico

University of North Carolina at Chapel Hill

University of Oklahoma

University of Oslo

University of Oxford

University of Pennsylvania

University of Perugia

University of Pittsburgh

University of Shizuoka

University of South Carolina

University of Southern California

University of Southern Denmark

University of South Florida

University of Tennessee

University of Texas, Galveston

University of Texas, San Antonio

University of Tokyo

University of Udine

University of Ulm

University of Valencia

University of Virginia

University of Washington

University of Zaragoza

Utrecht University

Vall d'Hebron Institute of Research, Galatea Clinic

Van Andel Research Institute

Vanderbilt University

Verastem, Inc.

Verlyx Pharma Inc

Vertex

V Foundation

Vion Pharmaceuticals

Virginia Mason Medical Center

Wake Forest University

Wilex

William Beaumont Hospitals

Wuhan Binhui Biotechnology Co., Ltd.

Yale University

Yiling Pharmaceutical Inc.

Zeria Pharmaceutical

Zhejiang Kanglaite Pharmaceutical Co.Ltd

Zhengzhou University

Organization Involved with Phase 1 Indications (104)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.